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Abstract
The physiopathology of obstructive sleep apnea-hypopnea syndrome
(OSAHS) is multifactorial and obesity has been shown to be one of the
main factors correlated with its occurrence. In obese patients with
anatomical alterations of the upper airways it is often difficult to
predict success for surgical correction since obesity is a limiting
factor. Therefore, the aim of the present study was to evaluate the
results of tonsillectomy in a specific group of patients, i.e., obese
OSAHS patients with tonsil hypertrophy. Seven OSAHS patients with
moderate obesity with obstructive palatine tonsil hypertrophy were
submitted to tonsillectomy. All patients were submitted to pre- and
postoperative appraisal of body mass index, otorhinolaryngology
examination and polysomnography. Patients’ average age was 36.4 ±
10.3 years and average preoperative body mass index was 36.6 ± 6.3
kg/m2. Postoperative weight did not differ significantly from preop-
erative weight (P = 0.27). Average preoperative apnea and hypopnea
index (AHI) was 81 ± 26/h and postoperative AHI was 23 ± 18/h (P =
0.0005). Average preoperative minimum oxyhemoglobin saturation
(SaO2 min) was 69 ± 14% and the postoperative value was 83 ± 3% (P
= 0.038). In relation to AHI, 6 (86%) of the 7 patients studied showed
a reduction of 50% in relation to preoperative level and of these, 4
(57%) presented AHI of less than 20%. Only one patient presented a
reduction of less than 50% in AHI, but even so showed improved SaO2
min. Tonsillectomy treatment for OSAHS in obese patients with
obstructive palatine tonsil hypertrophy caused a significant reduction
in AHI, with improvement in SaO2 min. This procedure could be
eventually considered as an option of treatment for obese OSAHS
patients with significant tonsil hypertrophy when continuous positive
air pressure therapy is not possible as the first choice of treatment.
Correspondence
F.L. Martinho
Rua Purpurina, 131, Conjunto 44




The authors neither received any
financial support nor had any
involvement with organization(s)
with financial interest in the
subject matter.
Publication supported by FAPESP.
Received June 28, 2005
Accepted March 30, 2006
Key words




• Apnea and hypopnea index
1138
Braz J Med Biol Res 39(8) 2006
F.L. Martinho et al.
Introduction
Obstructive sleep apnea and hypopnea
syndrome (OSAHS) is a prevalent condi-
tion, with 2% of women and 4% of men
reporting excessive daytime sleepiness and
an apnea and hypopnea index (AHI) of over
5 per sleep hour determined by polysomnog-
raphy (1). The physiopathology of OSAHS
is multifactorial and derives in part from
upper airway or craniofacial anatomical al-
terations associated with alterations of the
neuromuscular pharynx (2). The highest
prevalence is among males and in the 40-
and 50-year-old groups (3). Other factors
such as obesity and upper airway or cranio-
facial anatomical alterations have also been
correlated with the disease (2). The main
upper airway anatomical alterations corre-
lated with OSAHS are enlarged tongue, soft
thick palate, web (membrane formed by low
insertion of the posterior pillar in the uvula)
posteriorized in relation to the oropharynx,
medialized tonsillar pillars, long and thick
uvula, hypertrophic tonsils, and modified
Mallampati classification (MMC) levels III
and IV (4-8). The MMC is graded according
to palatal length and tongue size: in level III
just part of the uvula and soft palate is vis-
ible, in level IV practically only the hard
palate is visible. Anatomical craniofacial al-
terations have also been correlated with
OSAHS, especially maxillary retro-projec-
tion (retrognathia) (6,9,10). Obesity is the
main factor correlated with the occurrence
and severity of OSAHS (11), although some
studies have indicated that the correlation
with severity is still controversial (11,12).
The incidence of OSAHS in obese per-
sons may vary from 39 to 95%, which raises
the question as to which factor causes some
obese patients and not others to present dis-
ease. However, few studies have followed
this line of research (13-16). Studies includ-
ing pre- and post-bariatric surgery polysom-
nography for the treatment of morbid obe-
sity have shown improvement in AHI after
weight loss (17,18), but in some cases there
is no cure for the disease, and obesity is not
the only factor related to its physiopathology
even in these patients (19,20). Pillar et al.
(21) showed that bariatric surgery was effec-
tive in maintaining weight reduction in 14
long-term patients (averaging 7.5 years of
treatment) but AHI increased again after this
period, showing that the treatment of obesity
was also of limited effectiveness in the treat-
ment of OSAHS and that the disease tends to
develop over the years.
Several forms of treatment have been
proposed to control the OSAHS, but con-
tinuous positive airway pressure (CPAP) has
been the most effective, and patients should
always be encouraged to use it. Some pa-
tients cannot tolerate the use of CPAP and in
these cases different therapeutic measures
may be required (22,23). Obesity has been
shown to be one of the limiting factors for
success in pharyngeal surgeries (24,25), and
therefore these surgical procedures are often
not suggested for obese patients even in the
presence of obstructive anatomical alter-
ations. In obese patients with obstructive
upper airway anatomical alterations, it is
difficult to predict the roles that these factors
play in the physiopathology of the disease in
each patient.
The aim of the present study was to evalu-
ate the effect of tonsillectomy in treating this
specific group of patients, i.e., obese OSAHS
patients with obstructive tonsil hypertrophy,
who had first been introduced to CPAP thera-
py, but did not tolerate or refused to use it.
 Patients and Methods
The study was conducted at a public
clinic for patients with sleep breathing dis-
turbances in the Otorhinolaryngology De-
partment and the Sleep Institute of Universi-
dade Federal de São Paulo (UNIFESP) from
March 2002 to December 2003. During this
period, 64 OSAHS patients were submitted
to oropharyngeal surgery (tonsillectomy with
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or without partial uvulectomy). None of the
64 patients were submitted to uvulopalato-
pharyngoplasty, a type of surgery that is no
longer performed in our service. The proto-
col used at the public clinic consists of di-
rected patient interview, anthropometric physi-
cal examination (body mass index, BMI),
and physical examination of the upper air-
ways and craniofacial features. During the
interview, patients were asked about symp-
toms related to the disease, such as snoring,
daytime sleepiness, breathing pauses, cog-
nitive deficit, mood alterations, and morning
migraine. They were also asked about the
presence of co-morbidities such as systemic
arterial hypertension, cardiac conditions, and
hypothyroidism. BMI was calculated using
the formula weight/height2.
Only 7 patients in the group as a whole
presented both obesity (BMI of 30 kg/m2 or
over) and obstructive tonsil hypertrophy and
were included in this report. The average age
of the patients (5 men and 2 women) was
36.4 ± 10.3 years (range: 23-54 years) and
average BMI was 36.6 ± 6.3 kg/m2 (maxi-
mum: 46.9 kg/m2).
The criterion used for the diagnosis of
obstructive tonsil hypertrophy was level III
and IV hypertrophy, i.e., 50 to 75% obstruc-
tion of the oropharyngeal orifice (level III)
or 75-100% obstruction (level IV) (4,5,8).
All 7 patients had difficulty in adapting to
overnight CPAP pressure titration or refused
to use it. In this group of patients, especially
due to the presence of obstructive tonsil
hypertrophy, tonsillectomy was proposed as
an alternative treatment option.
All patients had been submitted to a full-
night polysomnography sleep study using
the SAC-Oxford, version 10.0, with electro-
encephalogram monitoring, submental and
tibial electromyogram, electrocardiogram,
airway flow measured by a nasal cannula
and oral thermistor, respiratory effort meas-
ured by thoracic-abdominal belts, oxyhemo-
globin saturation measured by a wrist oxime-
ter, and snoring and sleeping position re-
cordings. All patients presented AHI of over
five and were therefore OSAHS patients
according to the criteria of the American
Academy of Sleep Medicine (26). After sur-
gery, all patients were again submitted to
polysomnography to evaluate the effect of
the surgical procedure on OSAHS. Pre- and
postoperative polysomnography findings
were analyzed statistically by the Wilcoxon
test.
Patients were submitted to surgery under
general anesthesia. The surgical technique
consisted of bilateral tonsillectomy by dis-
section, closing the tonsil fossa on two planes
separately (muscular first and mucosa sec-
ond), with or without partial uvulectomy
(removal of only the tip of the uvula when it
was redundant).
The present study was approved by the
UNIFESP Ethics Committee and written in-
formed consent was obtained from all pa-
tients.
Results
The results of the physical examinations
are shown in Table 1 and the results of pre-
and postoperative polysomnography are
shown in Table 2. Postoperative polysom-
nography was performed on average 65 days
after the surgical procedure (range: 7-13
Table 1. Physical examination of the 7 obese
patients with obstructive sleep apnea hypopnea
syndrome studied.
N = 7 %
Retrognatia 0 0
Narrow hard palate 2 29.0
Web palate 5 71.4
Enlarged tongue 2 28.6
Abnormal soft palate 1 14.3
Abnormal uvula 5 71.4
Tonsil level III 4 57.1
Tonsil level IV 3 42.9
MMC level III 4 57.1
MMC level IV 3 42.9
MMC = modified Mallampati classification.
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weeks). The average preoperative and post-
operative AHI were 81 ± 26 and 23 ± 18/h,
respectively; and average oxyhemoglobin
saturation (SaO2 min) was 69 ± 14% preop-
eratively and 83 ± 3% postoperatively. There
was a statistically significant improvement
in AHI and SaO2 min after the surgical pro-
cedure. Regarding the polysomnography
parameters, we also observed significant
improvement in percentage of slow wave
sleep (stages 3 and 4 of NREM sleep; Table
2). Six (86%) of the 7 patients studied showed
a reduction of AHI of at least 50% compared
to the preoperative level. Patients’ average
weight was 112 ± 30 kg at the time of the
preoperative polysomnography and 107 ±
33 kg at the time of the postoperative poly-
somnography, thus not showing a signifi-
cant variation (P = 0.27) that could interfere
with the polysomnography results (Table 3).
Patients stayed in the hospital for only 1
day after surgery. Only 1 patient presented
breathing discomfort after the end of anes-
thesia and was submitted to temporary tra-
cheotomy. This patient was also released the
day after the surgical procedure and was
decannulated on the 7th day after surgery.
No other postoperative complications were
observed.
Discussion
There is no doubt that the first choice of
treatment for obese patients with moderate
to severe OSAHS is CPAP therapy. Another
treatment is considered only if these patients
do not adhere to or refuse CPAP use. Many
studies have shown that obesity and severity
of disease are limiting factors for the success
of pharyngeal surgeries (24,25,27,28), a fact
that often discourages surgeons from per-
forming more aggressive pharyngeal proce-
dures (especially uvulopalatopharyngoplas-
ty) in these patients. On the other hand, we
Table 3. Patient data.
Patient Age (years) AHI Preop. AHI Postop. SaO2 min Preop. SaO2 min Postop. Surgery
1 29 106 8 51% 84% To
2 54 63 11 82% 85% To + Uv
3 36 95 40 60% 81% To
4 23 105 29 66% 85% To
5 30 92 53 71% 79% To
6 40 36 6 91% 82% To
7 43 73 17 60% 88% To + Uv
Mean ± SD 36 ± 10 81 ± 26 23 ± 18 69 ± 0.14 83 ± 0.03
AHI = apnea and hypopnea per sleep hour index; Preop. = preoperative; Postop. = postoperative; SaO2 min
= minimum oxyhemoglobin saturation; To = tonsillectomy; Uv = partial uvulectomy.
Table 2. Pre- and postoperative polysomnography parameters of the patients studied.
SE AHI S1 S2 S3/4 REM SaO2 min
Preoperative 90 ± 4% 81 ± 26 9 ± 9% 71 ± 5% 6 ± 6% 14 ± 14% 69 ± 14%
Postoperative 88 ± 10% 23 ± 18* 7 ± 5% 60 ± 9% 16 ± 5%* 16 ± 9% 83 ± 3%*
Data are reported as means ± SD. SE = sleep efficiency; AHI = apnea and hypopnea per sleep hour index; S1
= percentage of stage 1 NREM sleep; S2 = percentage of stage 2 NREM sleep; S3/4 = sum of stages 3 and 4
of NREM sleep; REM = percentage of REM sleep; SaO2 min = minimum oxyhemoglobin saturation.
*P ≤ 0.05 compared to preoperative values (Wilcoxon test).
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think that a less aggressive and more physi-
ological pharyngeal surgical procedure such
as tonsillectomy should eventually be con-
sidered as an option for the treatment of
obese OSAHS patients with significant ton-
sil hypertrophy when CPAP therapy is not
possible as the first choice of therapy.
Studies attempting to correlate the pres-
ence of anatomical alterations with disease
severity found the highest correlations for
tonsil hypertrophy and MMC (score levels
of III and IV) (4,5). Zonato et al. (4) showed
that only 14.4% of OSAHS patients have
significant tonsil hypertrophy (levels III or
IV), which shows that this physical abnor-
mality is not observed in the majority of
OSAHS patients. Considering the degree of
obesity of OSAHS patients, Zonato et al.
(29) reported in a series of 624 patients that
39.5% of public patients and 39.6% of pri-
vate patients had a BMI over 30 kg/m2.
Moderately obese patients (BMI over 30 kg/
m2) also having tonsil hypertrophy (levels
III or IV) may be a rare situation, with these
patients representing a minority group among
OSAHS patients as a whole. In view of this
situation, we think that the data of this small
case report series, as a preliminary study,
may be relevant to show that tonsillectomy
can be performed safely, and may lead to
significant improvement in polysomnogra-
phy data.
Our data did not show a complete resolu-
tion of the disease, but definitely represented
substantial improvement in AHI severity,
oxyhemoglobin saturation and sleep quality
(increase in NREM sleep 3 and 4). Although
all patients presented significant improve-
ment in AHI and SaO2 min, the level of
improvement varied. The preoperative AHI
of the 7 patients was quite high, with respec-
tive values of 106, 105, 95, 92, 73, 63, and
36. After surgery, the highest AHI was 53/h.
These data represent a significant change
and perhaps a treatment option to be consid-
ered for specific patients. There was no cor-
relation of this variation with other param-
eters such as age, BMI or the presence of
craniofacial alterations visualized by physi-
cal examination. We did not identify any
factor that might predict which patients would
benefit most or least from surgery.
This study has considerable limitations
regarding the number of treated patients, the
absence of a control group and the short-
term follow-up data. Surgical procedures
usually show different results in long-term
follow-up. Our purpose was to show that a
simple and physiological procedure such as
tonsillectomy may be a possibility for an
uncommon group of patients, i.e., those with
moderate obesity and huge tonsils who are
unable to adhere to another therapy. These
data are the preliminary results of a case
report series and future studies are still needed
and should be encouraged.
We performed tonsillectomy in this group
of patients, first because we did not have
another option (since CPAP was not ac-
cepted), and second, because all of them had
huge tonsils, and also because it is known
that treatment of obesity alone is often not
enough to cure OSAHS patients (19-21).
We believe that for obese patients the cor-
rection of obstructive upper airway anatomi-
cal alterations (tonsil hypertrophy levels III
and IV) may be considered as a possibility
for therapy, not as a routine, but for selected
patients.
We showed here that tonsillectomy as a
treatment for OSAHS in obese patients with
tonsil hypertrophy led to a significant reduc-
tion in AHI, improvement in SaO2 min and
better quality of sleep (improvement in slow
wave sleep). These data are the preliminary
results of a small case report series, but may
encourage future investigations. Tonsillec-
tomy may be eventually considered as an
option of treatment for obese OSAHS pa-
tients with significant tonsil hypertrophy,
when CPAP therapy is not possible as the
first choice of therapy.
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